Acute symptomatic hyponatremia after ecstasy (3,4 methyldioxymethamphetamine; MDMA) ingestion is well documented and has been attributed to the syndrome of inappropriate antidiuretic hormone (SIADH). We report the case of an 18-year-old woman who took five tablets of ecstasy in a suicide attempt and drank 1700 ml water at the Emergency Department (ED). The laboratory findings obtained 5 h after ingestion showed a serum sodium concentration of 130 mmol/l, plasma osmolality of 264 mOsm/kg, urinary osmolality of 335 mOsm/kg and natriuresis of 101 mmol/l. The plasma arginine vasopressin level by radioimmunoassay was 33.7 pmol/l 5 h after ingestion. A gas chromatography-mass spectrometry assay confirmed MDMA in blood samples, with serum concentrations of 0.87 mg/l on arrival. This case report strongly suggests that MDMA reduces serum sodium levels through the dual pathways of SIADH and polydipsia. Accordingly, we believe that hyponatremia may be prevented in ED patients after MDMA ingestion by the early restriction of water intake.
Introduction
Ecstasy (3,4 methyldioxymethamphetamine; MDMA) is a recreational drug. Acute symptomatic hyponatremia after MDMA ingestion is well documented, and has been attributed to the syndrome of inappropriate antidiuretic hormone (SIADH) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . We report a case of intentional MDMA ingestion, in which we obtained serial measurements of serum sodium, plasma osmolality, urine sodium, urine osmolality, arginine vasopressin (AVP), and MDMA levels.
Case report
An 18-year-old woman took five tablets of ecstasy (60 mg each; 5 mg/kg in total) in a suicide attempt and arrived at our Emergency Department (ED) 3 h later. She denied ingesting any other medication or substances and had drunk only 200 ml water before arrival. On arrival, she only complained of a headache (visual analogue pain scale 5) [11] and she felt thirsty. Her vital signs were: temperature 37.51C (tympanic); respiratory rate 32 breaths per minute; pulse 145 beats per minute; and blood pressure in supine position 155/85 mmHg and blood pressure in standing position 150/80 mmHg. She had mydriasis and appeared anxious, but her physical examination was otherwise unremarkable. In particular, her mucous membranes appeared moist, her lungs were clear, she had no significant jugular venous distension or peripheral oedema, and her neurological examination was normal. Her initial laboratory test results were: serum sodium 136 mmol/l; potassium 3.8 mmol/l; blood urea nitrogen 2.7 mmol/l; creatinine 62 mmol/l; bicarbonate 22 mmol/l; plasma osmolality 290 mOsm/kg; urinary osmolality 420 mOsm/kg; and urine sodium 110 mmol/l. Electrocardiogram showed sinus tachycardia. A urine toxicological screening examination only revealed the presence of methamphetamines.
During the first hour of being in the ED, she complained of extreme thirst, and drank 1700 ml water as a result of free access to water and careless staff. She complained that her headache felt more severe (visual analogue pain scale 8). She remained anuric for the first 3 h of her ED course. Five hours after ingestion, we repeated her laboratory tests and found: serum sodium 130 mmol/l; potassium 3.0 mmol/l; blood urea nitrogen 2.0 mmol/l; creatinine 55 mmol/l; bicarbonate 20.4 mmol/l; plasma osmolality 264 mOsm/kg; urinary osmolality 335 mOsm/ kg and urine sodium 101 mmol/l. At the same time, her plasma AVP level by radioimmunoassay was 33.7 pmol/l (normal < 5.6 pmol/l).
Subsequently, a gas chromatography-mass spectrometry assay confirmed MDMA in blood samples, with serum concentrations of 0.87 mg/l on arrival. In response to her decreasing serum sodium and plasma osmolality, we instituted water restriction. Over the next few hours, her headache spontaneously disappeared, in parallel with the normalization of her measured biochemical parameters ( Figure 1 ). Four hours after arrival in the ED diuresis appeared and 10 h after ingestion her hydric
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balance was in equilibrium. She was admitted to the hospital and discharged after psychiatric evaluation on the third day.
Discussion
Hyponatremia is a well-documented consequence of acute MDMA ingestion [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Numerous studies have attributed hyponatremia in this setting to the syndrome of SIADH [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 12, 13] . Two studies have shown that a single small dose of MDMA (40 mg) or its metabolites can significantly increase the serum AVP concentration in humans [12, 13] . In-vitro experiments have supported these findings as MDMA and its metabolites contribute to AVP secretion on the rat hypothalamus [14] . The reason for AVP secretion after MDMA ingestion is unknown, although animal models suggest that MDMA stimulates AVP secretion along serotonergic pathways [15] . Nevertheless, it has also been suggested that MDMA-induced hyponatremia is unlikely to take place without excessive water ingestion as well [10, 12, 13] .
Our case supports the hypothesis that MDMA reduces serum sodium levels through the dual pathways of SIADH and polydipsia. First, we were able to confirm the early and inappropriate secretion of AVP through serial measurements of MDMA and AVP. Second, we directly observed our patient to have an early onset of increased thirst and excessive water intake 3 h after MDMA ingestion, despite being clinically euvolemic. Furthermore, when we intervened with water restriction, we observed a reversal in her decreasing serum sodium levels and a resolution of her clinical symptoms.
The mechanism of thirst after ecstasy ingestion is unknown. The osmolality could not be the reason in our case. A possible cause could be a direct MDMA action on the thirst centre. There are also some other possible mechanisms of indirect MDMA action on the thirst centre such as over serotonin neurons or angiotensin metabolism [15] .
Of interest is the fact that we were also able to show the time course of this AVP elevation, which deceased rapidly between 5 and 7 h after MDMA ingestion. Despite a large free water load, when water restriction was initiated early, the patient's serum sodium level also began to increase in this 5-7 h post-ingestion window, returning to baseline by 12 h post-ingestion. This suggests that patients should be observed for an appropriate time interval after MDMA ingestion.
In conclusion, this case report strongly suggests that acute hyponatremia after MDMA ingestion is the result of the inappropriate secretion of AVP coupled with excessive water intake. Accordingly, we believe that hyponatremia may be prevented in ED patients after MDMA ingestion with the early restriction of water intake. We recommend serum sodium determination in all symptomatic patients after MDMA ingestion. 
